The URL can be used to link to this page

Browse Search

Home My WebLink About20201734.tiffRESOLUTION RE: APPROVE AGREEMENT FOR PERSONAL PROTECTIVE EQUIPMENT (PPE) DECONTAMINATION SERVICES AND AUTHORIZE CHAIR TO SIGN - BATTELLE MEMORIAL INSTITUTE WHEREAS, the Board of County Commissioners of Weld County, Colorado, pursuant to Colorado statute and the Weld County Home Rule Charter, is vested with the authority of administering the affairs of Weld County, Colorado, and WHEREAS, the Board has been presented with an Agreement for Personal Protective Equipment (PPE) Decontamination Services between the County of Weld, State of Colorado, by and through the Board of County Commissioners of Weld County, on behalf of the Office of Emergency Management, and the Battelle Memorial Institute, commencing upon full execution of signatures, with further terms and conditions being as stated in said agreement, and WHEREAS, after review, the Board deems it advisable to approve said agreement, a copy of which is attached hereto and incorporated herein by reference. NOW, THEREFORE, BE IT RESOLVED by the Board of County Commissioners of Weld County, Colorado, that the Agreement for Personal Protective Equipment (PPE) Decontamination Services between the County of Weld, State of Colorado, by and through the Board of County Commissioners of Weld County, on behalf of the Office of Emergency Management, and the Battelle Memorial Institute, be, and hereby is, approved. BE IT FURTHER RESOLVED by the Board that the Chair be, and hereby is, authorized to sign said agreement. The above and foregoing Resolution was, on motion duly made and seconded, adopted by the following vote on the 10th day of June, A.D., 2020. BOARD OF COUNTY COMMISSIONERS WELD COUNTY, COLORADO ATTEST: da:64,0 udCaie1 Weld County Clerk to the Board unty Attorney Date of signature: OCola3(o`l0 Mike Freeman, Chair Steve ,M oreno..Pro-Tem Kevin D. Ross cc : o EM a RR) 7/02/20 2020-1734 EM0019 • arltrcct Z O It 31©7 BOARD OF COUNTY COMMISSIONERS PASS-AROUND REVIEW PASS-AROUND TITLE: Batelle Agreement DEPARTMENT: OEM DATE: June 2,2020 PERSON REQUESTING: Roy Rudisill Brief description of the problem/issue: Commissioners, attached is an agreement with Battelle, they are a company the State contracted with to decontaminate N95 PPE masks to help support the supply chain. In order to use the system, we need to sign an agreement with the company to use their process to decontaminate the masks. The agreement will cover all Weld County Departments and the Sheriff's Office. I've attached a product information sheet. Gabe Kalousek from the Attorney's Office has reviewed the agreemet and approved the agreement after a few edits. There are no costs to the County for the use of the system as it is paid for through federal funds to the State. If that funding runs out, we will be notified of the costs for the process of masks. I request the Board approve adding this agreement to the BOCC agenda for approval. What options exist for the Board? (include consequences, impacts, costs, etc. of options): Approve and add the agreement to the BOCC agenda. Decontamination of the N95 masks will save money and is a better use of PPE Recommendation: Approve request to add the agreement to the Agenda. Approve Schedule Recommendation Work Session Other/Comments: Mike Freeman,Chair E Scott K.James Barbara Kirkmeyer Steve Moreno, Pro-Tern I Kevin D. Ross l ' 2020-1734 007/0 51100167 PERSONAL PROTECTIVE EQUIPMENT (PPE) DECONTAMINATION SERVICES AGREEMENT WHEREAS, on March 12, 2020, the World Health Organization declared COVID-19 a pandemic. On March 13, 2020, the President of the United States declared a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak; WHEREAS, the Food and Drug Administration on March 29th, 2020 issued an Emergency Use Agreement ("EUA") authorizing Battelle Memorial Institute to operate the Battelle Critical Care Decontamination System (CCDS)TM for use in decontaminating compatible N95 or N95 -equivalent respirators ("compatible N95 respirators") for reuse by healthcare personnel (HCP)1 to prevent exposure to pathogenic biological airborne particulates when there are insufficient supplies of Filtering Facepiece Respirators (FFR) during the COVID-19 pandemic; WHEREAS, on April 10th, 2020 the Defense Logistics Agency, under authority of 10 U.S.C. 2304(c)(2), FAR Part 6.302-2, issued a contract to Battelle Memorial Institute to operate the CCDSTM, in accordance with conditions of the EUA, to decontaminate compatible N95 respirators at site locations throughout the United States as directed by the U.S. Government (the "DLA Contract"). Under this program, qualifying customers can submit qualifying PPE to be decontaminated at a Battelle approved facility without cost to the customer; WHEREAS, Client and Battelle acknowledge and understand that the provision of these services is intended to be within the scope of the Public Readiness and Emergency Preparedness Act ("PREP Act") and the PREP Act COVID-19 declaration by the U.S. Department of Health and Human Services, effective as of February 4, 2020; WHEREAS, the EUA directs and requires Battelle to enter into agreements with customers requesting decontamination of compatible N95 respirators prior to providing such services to the facility; and THEREFORE, now comes Battelle and Weld County Goverment (and at Client's option, its affiliates and/ or subsidiaries) ("Client"), referred to herein individually as a "Party" and collectively as the "Parties", to set forth the terms and conditions under which a customer can elect to participate in this program. 1. DURATION OF AGREEMENT This Agreement shall begin upon execution and last indefinitely until any one of the following occurrences: a) The Client notifies Battelle in writing that it no longer wishes to participate in the program; b) The DLA Contract under which this program operates expires or is terminated by the US Government; c) The US Government directs Battelle to no longer operate at the site location used by Client and an alternate location is not available; d) The EUA is revoked by the FDA pursuant to Section 564(b)(2) of the Federal Food, Drug, and Cosmetic Act; e) The participating healthcare facility violates the terms and conditions of this agreement, or any applicable US law or regulation governing this program, or whose status changes so that it no longer qualifies as an eligible healthcare facility; or 1 Healthcare personnel ("HCP") refers to all paid and unpaid persons serving in healthcare settings who have the potential for direct or indirect exposure to patients or infectious materials, including body substances (e.g., blood, tissue, and specific body fluids); contaminated medical supplies, devices, and equipment; contaminated environmental surfaces; or contaminated air. These HCP include, but are not limited to, emergency medical service personnel, nurses, nursing assistants, physicians, technicians, therapists, phlebotomists, pharmacists, dentists and dental hygienists, students and trainees, contractual staff not employed by the healthcare facility, and persons not directly involved in patient care, but who could be exposed to infectious agents that can be transmitted in the healthcare setting (e.g., clerical, dietary, environmental services, laundry, security, engineering and facilities management, administrative, billing, and volunteer personnel. oZoao-/73L Page 2 of 5 f) Funding of the program is exhausted and is not available to continue processing N95 respirators. g) Battelle may terminate this agreement at its convenience for any reason. h) Battelle is unable to continue to process PPE for decontamination due to a force majeure event as described in Section 10 below. Battelle will notify Client upon occurrence of any of the preceding events as soon as practical. In no event will Battelle be responsible to process PPE submitted by Client after occurrence of any of the preceding events regardless of Client's expectations or reliance on the program. Battelle will not be liable for any costs of substitute decontamination services sought by Client subsequent to the end of this program. 2. SERVICES PROVIDED Battelle will provide decontamination services to Client for hospital Personal Protective Equipment (PPE), limited to the PPE approved by the FDA as set forth in EUA for decontamination processing. Battelle will receive and store contaminated PPE prior to decontamination. Battelle will decontaminate and repackage PPE. Battelle will deliver a chain of custody form (or equivalent) indicating conditions of the decontamination implementation process in addition to chemical indicators which will be used to qualify each decontamination cycle will be provided for each decontamination cycle performed for all PPE upon retrieval. Battelle will comply with the terms and conditions of the EUA. If Client wishes to have Battelle assist in the transportation of PPE to and from Client, Client can request such assistance. In response, and at Battelle's sole discretion, Battelle may provide a subcontractor to coordinate transportation of PPE to and from the Battelle approved decontamination facility to Client location. These services will be provided to the Client at no cost. 3. CLIENT'S RESPONSIBILITIES a. Client will be responsible for preparing PPE for transportation in the manner described in the instructions provided to Client b. Client shall make available to HCP who are or may be using the decontaminated respirators the authorized Fact Sheet for Healthcare Personnel that is required to be provided by Battelle. c. Client shall monitor HCP who use such respirators for the signs and symptoms of potential infection with SARS-CoV-2 or other respiratory infection and promptly report such information to Battelle, so that Battelle can provide a weekly report to FDA. Reports of adverse health indications should be reported up to and including 14 days after the last contact with suspected SARS-CoV-2 virus. d. Client shall inspect the decontaminated respirators upon receipt from Battelle. Any discoloration or other signs of degradation with a decontaminated respirator should promptly be reported to Battelle, and the healthcare facility should dispose of such respirator. e. The maximum number of times a N95 respirator can undergo the decontamination cycle is twenty (20) and the Client shall not submit N95 respirators that have reached this limit for decontamination. f. Client shall provide Battelle with a complete list of all subsidiaries and/or affiliates who utilize Services provided for in this Agreement. Client is responsible for obtaining a three - digit site code for each Client location that will be utilizing the Services provided for in this Agreement. g. Client shall make the literature listed in Section 4 below available to all subsidiaries and/or affiliates who utilize the Services provided for in this Agreement. Page 3 of 5 h. Client shall certify that the personnel benefiting from the use of the Services herein are Healthcare Personnel as provided for in the EUA. 4. RECEIPT OF LITERATURE Client acknowledges that it has received the following literature from Battelle related to this program. • Instructions for Healthcare Personnel: Preparation of Compatible N95 Respirators for Decontamination by the Battelle Memorial Institute Using the Battelle Decontamination System (Instructions for Healthcare Personnel"); • Instructions for Healthcare Facilities: Preparation and Collection of Compatible N95 Respirators for Decontamination by the Battelle Memorial Institute Using the Battelle Decontamination System ("Instructions for Healthcare Facilities"); and • Labeling and instructions for use developed by Battelle that include the Fact Sheet, Instructions for Healthcare Personnel, and Instructions for Healthcare Facilities. 5. WARRANTY AND LIMITATION OF LIABILITY ALL SERVICES ARE PROVIDED TO CLIENT AS -IS. BATTELLE MAKES NO OTHER WARRANTY OR GUARANTEE, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF FITNESS FOR A PARTICULAR PURPOSE, MERCHANTABILITY, OR FOR ANY PARTICULAR RESULT. Notwithstanding any other provision of this Agreement to the contrary, in no event shall either Party be liable to the other for any indirect, incidental, special, punitive, or consequential damages, arising from or in connection with this Agreement and regardless of the cause of action or theory of law asserted. In no event shall Battelle's maximum cumulative liability, regardless of the cause of action or theories of law asserted, exceed the total amount paid by Client to Battelle under this Agreement. 6. LIABILITIES Each Party agrees to be responsible for any liability, claim, loss, damage or expenses, including without limitation, reasonable attorney fees, arising from its negligent acts or omissions in connection with its performance of this Agreement, or its failure to comply with the terms of this Agreement, as determined by a court of competent jurisdiction. Liability for claims for injuries to persons or property arising from the negligence of the Client, its departments, boards, commissions committees, bureaus, offices, employees and officials shall be controlled and limited by the provisions of the Colorado Governmental Immunity Act, §24-10-101, et seq. No term or condition of this Contract shall be construed or interpreted as a waiver, express or implied, of any of the immunities, rights, benefits, protections, or other provisions, contained in these statutes. 7. COMPLIANCE WITH LAWS The Parties agree to comply with all laws and regulations applicable to the performance of their respective obligations under this Agreement, including those related to export control, and neither Party shall export nor re-export any tangible goods, service or information related to this Agreement without first obtaining any required export licenses or other governmental approvals, if required by law. Each Party is responsible for its own compliance with this provision. 8. NON -ENDORSEMENT AND USE OF NAME Page 4 of 5 Client agrees that it will not use or imply Battelle's name or marks, or use Battelle's reports, for advertising, promotional purposes, raising of capital, recommending investments, or in any way that implies endorsement by Battelle without Battelle's prior written approval. 9. FORCE MAJEURE Neither Client nor Battelle shall be liable for any expenses, losses or damages (except payment of monetary obligations) resulting from delay or failure to perform caused by acts beyond the control of the Party delayed or unable to perform including, without limitation, acts or failure to act of government, war, acts of terror, civil unrest, extreme weather conditions, and pandemics (a "Force Majeure Event"). In the event of any delay or failure to perform occasioned by the foregoing, the time for performance will be extended by a period of time equal to the time lost by reason of such delay or failure to perform and any other affected provision(s) of the Agreement including, without limitation, price, shall be equitably adjusted provided that the Party delayed or unable to perform provided the other Party with written notice of the occurrence and impact of the Force Majeure Event. 10. MISCELLANEOUS Each Party is, at all times, acting as an independent contractor under this Agreement and not as an agent, employee, joint venturer or partner of the other. This Agreement may not be assigned in whole or in part without the prior written consent of both Parties, which shall not be unreasonably withheld or delayed. This Agreement shall be binding upon, inure to the benefit of, and be enforceable by and against the successors and permitted assigns of each Party. Battelle makes no commitments with regards the time necessary to complete the decontamination process once PPE is received from the Client. Processing time will be dependent on the amount of PPE received from numerous health care providers. The failure by one Party to require performance of any provision or to exercise any right, remedy or option available under this Agreement shall not affect that Party's right to require performance or to exercise such right, remedy or option at any time thereafter, nor shall a waiver of any breach or default of this Agreement constitute a waiver of any subsequent breach or default or a waiver of the provision itself. If any part of this Agreement shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other part of this Agreement. This Agreement may be modified or amended only by mutual agreement in writing. Battelle may require additional conditions of participation at any time in order for client to continue participation. No course of dealing, usage of trade, waiver, or non -enforcement shall be construed to modify or otherwise alter the terms and conditions of this Agreement. This Agreement represents the entire agreement of the Parties and supersedes any prior discussions or understandings, whether written or oral, relating to the subject matter hereof and neither Party makes any representations other than as expressly set forth in this Agreement. In the event of any conflict or inconsistency between these terms and conditions and those of any Task Order, these terms and conditions shall control. Clauses 5, 6, 7, 8, 9, and 10 shall survive termination or expiration of this Agreement. IN WITNESS WHEREOF, the terms and conditions of this agreement are accepted by Client. [signature page to follow] Page 5 of 5 BATTELLE MEMORIAL INSTITUTE WELD COUNTY BY: 3r_..3r,______ BY: A-a&L7 7/11.1,11,01-;•P NAME: Mike Freeman NAME: Katelyn Murwin TITLE: Chair, Board of Weld County TITLE: Contracts Representative Commissioners DATE: 06/02/2020 DATE: 06/02/2020 CLIENT INFORMATION (REQUIRED): ADDRESS: 1150 "0" Street CITY: Greeley STATE: W ZIP: 80631 PHONE: 970-400-4200 EMAIL: rrudisill@weldgov.can FACT SHEET FOR HEALTHCARE PERSONNEL Battelle Qeconpamipation System for Decontarntnating Coropable N9S 9:e pirators March 29,~2020 Coronavirus Disease 2019 You have been given a decontaminated N95 or N95 - equivalent respirator that has been decontaminated using a decontamination system for reuse by healthcare personnel in a healthcare setting to help prevent healthcare personnel exposure to pathogenic biologic airborne particulates during the COVID-19 pandemic. This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of decontaminated N95 or N95 -equivalent respirators. These compatible N95 or N95 -equivalent respirators have been decontaminated using the Battelle CCDS Critical Care Decontamination System TM (hereafter referred to as "decontaminated N95 respirators" and "Battelle Decontamination System" throughout this Fact Sheet). Decontaminated N95 respirators that have been decontaminated using the Battelle Decontamination System are authorized for use by healthcare personnel in a healthcare setting during the COVID-19 pandemic. Whether or not you use a respirator, always follow infection control measures: wash hands, cover coughs and sneezes, stay home if you may be sick. What are the symptoms of COVID-19? Many patients with confirmed COVID-19 have developed fever and/or symptoms of acute respiratory illness (e.g., cough, difficulty breathing). However, limited information is currently available to characterize the full spectrum of clinical illness associated with COVID-19. Based on what is known about the virus that causes COVID-19, signs and symptoms may appear any time from 2 to 14 days after exposure to the virus. Based on preliminary data, the median incubation period is approximately 5 days, but may range 2-14 days. Public health officials have identified cases of COVID-19 infection throughout the world, including the United States, which may pose risks for public health. Please check the CDC webpage for the most up to date information. What do I need to know about the emergency use of decontaminated N95 respirators? • The Battelle Decontamination System has been authorized for emergency use to decontaminate compatible N95 or N95 -equivalent respirators for reuse by healthcare personnel during the COVID-19 pandemic to prevent wearer exposure to pathogenic airborne particulates. o Compatible N95 or N95 -equivalent respirators under the Battelle Emergency Use Authorization are those that do not contain cellulose -based materials. • Successful testing on decontaminated N95 respirators demonstrated acceptable performance through 20 decontamination cycles for sporicidal activity, viricidal activity, filtration efficiency, breathability, form fit testing, and strap integrity testing, per authorized respirator. • Use of decontaminated N95 respirators: ✓ Inspect respirators after each use prior to submission for decontamination ✓ Discard respirators with visible soiling (e.g., blood) or damage — do not use and do not send for decontamination ✓ Cellulose -based materials are incompatible with the Battelle decontamination process ✓ The number of times a respirator has been decontaminated is written on the respirator (maximum 20 times) ✓ Report problems with decontaminated N95 respirators to your healthcare facility Monitor healthcare personnel for signs and symptoms of potential infection with SARS-CoV-2 or other respiratory infection for up to and including 14 days after last contact with the SARS-CoV-2 virus and related material, and promptly report such information to Battelle. • Report damage or discoloration observed upon receipt of the decontaminated N95 respirators, and Report Adverse events, including problems with test performance or results, to MedWatch by submitting the online FDA Form 3500 (https://www.accessdata.fda.Qov/scripts/medwatch/index.cfm?action=reportino.home) or by calling 1 -800 -FDA -1088 ljPage FACT SHEET FOR HEALTHCARE PERSONNEL Battelle [ epntatnitta�la m fpr De ontaminating-Compatible N95 Resp►rators �"+.ht`,t;�°" Marts 29, 20, i Coronavirus Disease 2019 potential exposure of healthcare personnel from breaks in or other damage to or degradation of the decontaminated N95 respirators. Use appropriate personal protective equipment (PPE) when caring for individuals suspected of having COVID- 19 as outlined in the CDC webpages, including Interim Infection Prevention and Control Recommendations for Patients with Confirmed Coronavirus Disease 2019 (COVID-19) or Persons Under Investigation for CO VID- 19 in Healthcare Settings, Infection Control, and FAQ about PPE. Current information on COVID-19 for healthcare personnel is available at CDC's webpage, Information for Healthcare Professionals (see links provided in "Where can I go for updates and more information" section). What are the known and potential benefits and risks of using decontaminated N95 respirators? Potential benefits include: • May help prevent exposure to airborne pathogens, and therefore risk of infection or illness • Extends the usability of compatible N95 or N95 - equivalent respirators by allowing for decontamination and reuse Potential risks include: • Failure of filtration efficiency • Reduced breathability • Strap failure and ineffective face -fit • Reused respirators may not have been effectively decontaminated of SARS-CoV-2 or other pathogens Overview of the Battelle Decontamination System The Battelle Decontamination System is a self-contained decontamination device that uses vapor phase hydrogen peroxide (VPHP) for decontamination of compatible N95 or N95 -equivalent respirators that are contaminated or potentially contaminated with SARS-CoV-2. N95 or N95 - equivalent respirators containing cellulose -based materials are incompatible with the Battelle decontamination process. Each decontamination cycle in the Battelle Decontamination System consists of injecting VPHP into the decontamination chamber until achieving a saturated atmosphere indicated by micro condensation; maintaining the VPHP exposure for a 150 -minute dwell time; and allowing the VPHP to off gas to a level of 1 ppm prior to post decontamination processing. A minimum of five calibrated chemical indicators are dispersed throughout the system to indicate a successful decontamination cycle. This decontamination system enables the reuse of compatible N95 or N95 -equivalent respirators that would otherwise be disposed of after a single use. However, respirators that are visibly soiled must be discarded and not reused or decontaminated. What is an EUA? The United States FDA has made the emergency use of the Battelle Decontamination System to decontaminate compatible N95 or N95 -equivalent respirators available under an emergency access mechanism called an Emergency Use Authorization (EUA). The EUA is supported by the Secretary of Health and Human Service's (HHS's) declaration that circumstances exist to justify the emergency use of medical devices, including alternative products used as medical devices, due to insufficient supply during the COVID-19 pandemic. The Battelle Decontamination System has been made available under an EUA, and has not undergone the same type of review as an FDA -approved or cleared device. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate, approved, available alternatives, and based on the totality of scientific evidence available, it is reasonable to believe that the Battelle Decontamination System may be effective at preventing healthcare personnel exposure to pathogenic airborne particulates during periods of insufficient respirator supply during the COVID-19 pandemic by decontaminating, for a maximum of 20 decontamination cycles per respirator, compatible N95 or N95 -equivalent respirators that are contaminated or potentially contaminated with SARS-CoV-2 or other pathogenic microorganisms. The EUA for the Battelle Decontamination System is in effect for the duration of the COVID-19 declaration Report Adverse events, including problems with test performance or results, to MedWatch by submitting the online FDA Form 3500 (https://www.accessdata.fda.gov/scripts/medwatch/index.cfm?action=reportinq.home) or by calling 1 -800 -FDA -1088 2IPage FACT SHEET FOR HEALTHCARE PERSONNEL Battelle Decontamination System for Decontaminating Compatible N95 Respirators March 29, 2020 Coronavirus Disease 2019 justifying emergency use of medical devices, unless terminated or revoked (after which the products may no longer be used). Where can I go for updates and more information? CDC webpaqes: General: https://www.cdc.gov/COVID19 Healthcare Professionals: https://www.cdc.gov/coronavirus/2019-nCoV/quidance- hcp.html Infection Prevention and Control Recommendations in Healthcare Settings: https://www. cdc.gov/coronavirus/2019-ncov/i nfection- control/control-recom me nd ati ons. htm l Infection Control: https://www.cdc.gov/coronavirus/2019- ncov/infection-control/i ndex. htm I FAQ on Personal Protective Equipment: https://www. cdc.gov/coronavirus/2019-ncov/hcp/respirator- use-faq. htm l FDA webpaqes: General: www.fda.gov/novelcoronavirus EUAs: https://www.fda.gov/medical-devices/emergencv- situations-medical-devices/emergency-use-authorizations Report Adverse events, including problems with test performance or results, to MedWatch by submitting the online FDA Form 3500 (https://www.accessdata.fda.gov/scripts/medwatch/index.cfm?action=reportinq.home) or by calling 1 -800 -FDA -1088 3IPage New Contract Request Entity information Entity Name* BAIIELLE Entity ID* @00042365 Contract Name* PERSONAL PROTECTIVE EQUIPMENT (PPE) DECON-lAMINATION SERVICES AGREEMENT Contract Status CTB REVIEW New Entity? Contract ID 3707 Contract Lead GMARQUUEZ. Contract Lead Email grnarquez@co weld.co.us Parent Contract ID Requires Board Approval YES Department Project # Contract Description* STATE CONTRACTED WITH TO DECONTAMINATE N95 PPE MASKS TO HELP SUPPORT THE SUPPLY CHAIN. Contract Description 2 Contract Type* CONTRACT Amount * 0 00 Renewable* YES Automatic Renewal Grant IGA Department OEM Department Email CM-OEM@weldgovcorn Department Head Email CM-OEM- DeptHead ti A.Idgov.corn County Attorney GENERAL COUNTY ATTORNEY EMAIL County Attorney Email CM- COUNTYATTORNEY@WELD GOV.COM Requested BOCC Agenda Date* 0611 0/2020 Due Date 061O6/2.020 Will a work session with BOCC be required?* NO Does Contract require Purchasing Dept. to be included? If this is a renewal enter previous contract ID If this is part of a MSA enter MSA Contract ID Note: the Previous Contract Number and Master Services Agreement Number should be left blank if those contracts are not in OnBase Contract Dates Effective Date Termination Notice Period Review Date * 04/30/2021 Committed Delivery Date Renewal Date* 053012021 Expiration Date Contact Information Contact Info Contact Name Contact Type Contact Email Contact Phone 1 Contact Phone 2 Purchasing Purchasing Approver Approval Process Department Head ROY RU0ISILL OH Approved Date 06`00/2020 Final Approval BOCC Approved BOCC Signed Date BOCC Agenda Date 06;10/2020 Originator GMARQUEZ Finance Approver BARB CONNOLLY Purchasing Approved Date Finance Approved Date 06.0912020 Tyler Ref # AG 061020 Legal Counsel GABE KALOUSEK Legal Counsel Approved Date. 06/09.,'2020 Hello